- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有61家主力机构披露2025-12-31报告期持股数据，持仓量总计1.99亿股，占流通A股33.70%
- 波段诊断：
-
技术面诊股
诊断结果：4.9技术面打败了37%的股票
技术面评分前10的股票
近期的平均成本为5.30元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为5.30元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.30","date":1775116979,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，明显跑输行业平均水平。
[{"date":"2026.04.03","stock":"-4.36","trade":"-2.48","ind":"-0.99"},{"date":"2026.04.02","stock":"-1.43","trade":"0.58","ind":"-1.60"},{"date":"2026.04.01","stock":"2.38","trade":"4.76","ind":"1.70"},{"date":"2026.03.31","stock":"-2.33","trade":"-0.80","ind":"-1.81"},{"date":"2026.03.30","stock":"-1.06","trade":"0.87","ind":"-0.25"},{"date":"2026.03.27","stock":"3.10","trade":"3.53","ind":"1.13"},{"date":"2026.03.26","stock":"0.55","trade":"-0.83","ind":"-1.41"},{"date":"2026.03.25","stock":"1.11","trade":"0.43","ind":"1.95"},{"date":"2026.03.24","stock":"4.86","trade":"3.52","ind":"1.43"},{"date":"2026.03.23","stock":"-7.05","trade":"-5.93","ind":"-3.76"},{"date":"2026.03.20","stock":"-3.32","trade":"-1.88","ind":"-0.25"},{"date":"2026.03.19","stock":"-2.89","trade":"-2.16","ind":"-2.02"},{"date":"2026.03.18","stock":"1.03","trade":"1.70","ind":"1.05"},{"date":"2026.03.17","stock":"-2.18","trade":"-0.59","ind":"-1.87"},{"date":"2026.03.16","stock":"0.17","trade":"0.44","ind":"0.19"},{"date":"2026.03.13","stock":"0.00","trade":"-0.27","ind":"-0.65"},{"date":"2026.03.12","stock":"-0.17","trade":"-0.77","ind":"-0.63"},{"date":"2026.03.11","stock":"-1.00","trade":"-0.78","ind":"0.78"},{"date":"2026.03.10","stock":"3.08","trade":"2.53","ind":"2.04"},{"date":"2026.03.09","stock":"-1.18","trade":"-0.71","ind":"-0.74"},{"date":"2026.03.06","stock":"2.60","trade":"3.05","ind":"0.59"}]
东宝生物,深证成指,生物制品指数
压力支撑
该股压力位为5.33元，支撑位为5.16元。
[{"text":"\u538b\u529b\u4f4d","value":"5.33","date":1775145600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.16","date":1775145600,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.7资金面打败了27%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体无进出。
更新时间：04月03日 20:30
| 机构今日流向(万元) | -1446.95 | 机构5日流向(万元) | 209.46 |
| 机构10日流向(万元) | 452.41 | 机构20日流向(万元) | -4625.72 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少1035.1万股，其中基金净增仓11家，主力净增仓19家，请投资者中长期谨慎为宜。
截止2025-12-31，共61家主力机构（基金56家，信托公司1家，一般法人3家，社保基金1家），持仓量总计19873.47万股，占流通A股33.70%
其中，基金持仓与2025-06-30相比：
增仓：15家 ，增持 218.29万股
减仓：4家 ，减持 10.34万股
新出现在主力名单中：37家 ，持有307.9万股
从主力名单中消失：18家 ，原持有745.3万股
其中，基金持仓与2025-06-30相比：
增仓：15家 ，增持 218.29万股
减仓：4家 ，减持 10.34万股
新出现在主力名单中：37家 ，持有307.9万股
从主力名单中消失：18家 ，原持有745.3万股
消息面诊股
诊断结果：5.9消息面打败了33%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 东宝生物：母公司其他应收款中关联方借款均为合并范围
2026-04-02 - 东宝生物：公司不存在滞销的情况
2026-04-02 - 东宝生物：公司业绩说明会交流内容可通过巨潮资讯网查
2026-04-02 - 2026年中国皮明胶行业市场规模、进入壁垒及投资战
2026-04-02 - 生物制品行业经营数据全景分析：创新药企领跑研发，规
2026-04-01 - 明胶不好卖了？东宝生物去年营收净利双降
2026-03-31 - 深耕胶原产业拓展应用场景 东宝生物2025年实现营
2026-03-30 - 财报速递：东宝生物2025年全年净利润5433.7
2026-03-30 - 东宝生物：董事会审议通过《2025年度总经理工作报
2026-03-29 - 东宝生物2025年营收、净利双降
2026-03-29
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-03-30 |
| 利好 | 分红转增 | 10派0.12元(含税) | 2026-03-30 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-30 |
| 一般消息 | 募资投向 | 2026-03-29 | |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-22 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-05-15 |
| 利好 | 分红转增 | 10派0.25元(含税) | 2025-04-24 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.5行业面打败了98%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2026.04.03","price":"-0.99","value":"-2.48"},{"date":"2026.04.02","price":"-1.60","value":"0.58"},{"date":"2026.04.01","price":"1.70","value":"4.76"},{"date":"2026.03.31","price":"-1.81","value":"-0.80"},{"date":"2026.03.30","price":"-0.25","value":"0.87"},{"date":"2026.03.27","price":"1.13","value":"3.53"},{"date":"2026.03.26","price":"-1.41","value":"-0.83"},{"date":"2026.03.25","price":"1.95","value":"0.43"},{"date":"2026.03.24","price":"1.43","value":"3.52"},{"date":"2026.03.23","price":"-3.76","value":"-5.93"},{"date":"2026.03.20","price":"-0.25","value":"-1.88"},{"date":"2026.03.19","price":"-2.02","value":"-2.16"},{"date":"2026.03.18","price":"1.05","value":"1.70"},{"date":"2026.03.17","price":"-1.87","value":"-0.59"},{"date":"2026.03.16","price":"0.19","value":"0.44"},{"date":"2026.03.13","price":"-0.65","value":"-0.27"},{"date":"2026.03.12","price":"-0.63","value":"-0.77"},{"date":"2026.03.11","price":"0.78","value":"-0.78"},{"date":"2026.03.10","price":"2.04","value":"2.53"},{"date":"2026.03.09","price":"-0.74","value":"-0.71"},{"date":"2026.03.06","price":"0.59","value":"3.05"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 三生国健 | 58.59% | 29.04% | 7.2分 |
| 2 | 荣昌生物 | 40.79% | 20.65% | 6.8分 |
| 3 | 诺诚健华 | 29.54% | 16.13% | 6.4分 |
| 4 | - | 26.28% | 20.29% | 分 |
| 5 | 君实生物 | 24.29% | 15.10% | 6.3分 |
| 6 | 赛伦生物 | 14.71% | 9.56% | 6.7分 |
| 8 | 通化东宝 | 9.51% | 11.24% | 6.1分 |
| 10 | 艾迪药业 | 8.80% | 15.04% | 6.1分 |
| 12 | *ST双成 | 5.21% | -8.79% | 5.4分 |
| 14 | 赛升药业 | 3.96% | 4.44% | 6.1分 |
| 16 | 欧林生物 | 3.64% | -0.54% | 5.7分 |
| 18 | 昊帆生物 | 1.92% | -1.20% | 4.0分 |
| 20 | 安科生物 | 1.35% | 5.62% | 6.0分 |
| 22 | 百普赛斯 | 1.24% | 7.63% | 5.7分 |
| 24 | 近岸蛋白 | 0.09% | 5.44% | 5.5分 |
| 26 | *ST四环 | -0.71% | -5.42% | 5.0分 |
| 28 | 西藏药业 | -1.01% | 2.89% | 5.5分 |
| 30 | 康泰生物 | -1.92% | -0.79% | 4.1分 |
| 32 | 华兰生物 | -4.38% | 0.48% | 5.5分 |
| 34 | 智飞生物 | -5.14% | 1.39% | 4.8分 |
| 36 | 天坛生物 | -6.61% | -1.85% | 5.0分 |
| 38 | 长春高新 | -6.87% | -2.13% | 4.0分 |
| 40 | 辽宁成大 | -7.59% | 0.90% | 5.2分 |
| 42 | 百克生物 | -7.72% | -2.51% | 4.4分 |
| 44 | 派林生物 | -9.05% | -2.74% | 4.7分 |
| 46 | 禾元生物 | -9.66% | -1.70% | 4.4分 |
| 48 | 万泽股份 | -10.01% | -3.11% | 5.3分 |
| 50 | 特宝生物 | -10.49% | -5.76% | 5.4分 |
| 52 | - | -10.85% | 2.76% | 分 |
| 54 | 博雅生物 | -12.26% | -1.27% | 4.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-12-31 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 10/71 ， 19/71。
[{"date":"2025-12-31","value":"3.14","vol":"3.64"},{"date":"2025-09-30","value":"2.80","vol":"-9.78"},{"date":"2025-06-30","value":"2.15","vol":"-0.61"},{"date":"2025-03-31","value":"1.10","vol":"0.46"},{"date":"2024-12-31","value":"5.06","vol":"-0.68"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.14 | 2.80 | 2.15 | 1.10 | 5.06 |
| 行业(%) | 3.64 | -9.78 | -0.61 | 0.46 | -0.68 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"23.36","vol":"72.24"},{"date":"2025-09-30","value":"24.53","vol":"67.61"},{"date":"2025-06-30","value":"25.44","vol":"68.28"},{"date":"2025-03-31","value":"25.06","vol":"68.43"},{"date":"2024-12-31","value":"22.72","vol":"69.85"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
23.36 | 24.53 | 25.44 | 25.06 | 22.72 |
| 行业(%) | 72.24 | 67.61 | 68.28 | 68.43 | 69.85 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 19/71 ， 18/71。
[{"date":"2025-12-31","value":"-15.78","vol":"46.60"},{"date":"2025-09-30","value":"-15.84","vol":"45.25"},{"date":"2025-06-30","value":"-16.93","vol":"6902.04"},{"date":"2025-03-31","value":"-22.23","vol":"6125.27"},{"date":"2024-12-31","value":"-9.19","vol":"47.35"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-15.78 | -15.84 | -16.93 | -22.23 | -9.19 |
| 行业(%) | 46.60 | 45.25 | 6902.04 | 6125.27 | 47.35 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"-36.80","vol":"48.35"},{"date":"2025-09-30","value":"-26.89","vol":"44.80"},{"date":"2025-06-30","value":"-28.00","vol":"5.44"},{"date":"2025-03-31","value":"-26.64","vol":"-8.46"},{"date":"2024-12-31","value":"-28.28","vol":"-9.81"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-36.80 | -26.89 | -28.00 | -26.64 | -28.28 |
| 行业(%) | 48.35 | 44.80 | 5.44 | -8.46 | -9.81 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 10/71 ， 3/71。
[{"date":"2025-12-31","value":"0.29","vol":"0.34"},{"date":"2025-09-30","value":"0.21","vol":"0.22"},{"date":"2025-06-30","value":"0.14","vol":"0.14"},{"date":"2025-03-31","value":"0.07","vol":"0.06"},{"date":"2024-12-31","value":"0.33","vol":"0.29"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.29 | 0.21 | 0.14 | 0.07 | 0.33 |
| 行业(次) | 0.34 | 0.22 | 0.14 | 0.06 | 0.29 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"1.51","vol":"1.09"},{"date":"2025-09-30","value":"1.04","vol":"0.92"},{"date":"2025-06-30","value":"0.74","vol":"0.56"},{"date":"2025-03-31","value":"0.39","vol":"0.26"},{"date":"2024-12-31","value":"2.15","vol":"1.17"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.51 | 1.04 | 0.74 | 0.39 | 2.15 |
| 行业(次) | 1.09 | 0.92 | 0.56 | 0.26 | 1.17 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 8/71 ， 8/71。
[{"date":"2025-12-31","value":"20.94","vol":"1.55"},{"date":"2025-09-30","value":"6.79","vol":"1.84"},{"date":"2025-06-30","value":"48.52","vol":"-1377.61"},{"date":"2025-03-31","value":"-19.96","vol":"-46.99"},{"date":"2024-12-31","value":"15.83","vol":"-11.33"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 20.94 | 6.79 | 48.52 | -19.96 | 15.83 |
| 行业 | 1.55 | 1.84 | -1377.61 | -46.99 | -11.33 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"0.81","vol":"1.31"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.60","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.88","vol":"2.01"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.81 | - | 0.60 | - | 0.88 |
| 行业 | 1.31 | 0.00 | 1.59 | 0.00 | 2.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 13/71 ， 12/71。
[{"date":"2025-12-31","value":"4.87","vol":"4.82"},{"date":"2025-09-30","value":"4.90","vol":"6.00"},{"date":"2025-06-30","value":"4.37","vol":"6.64"},{"date":"2025-03-31","value":"4.49","vol":"7.75"},{"date":"2024-12-31","value":"3.81","vol":"6.72"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 流动比率 |
4.87 | 4.90 | 4.37 | 4.49 | 3.81 |
| 行业 | 4.82 | 6.00 | 6.64 | 7.75 | 6.72 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"3.12","vol":"3.38"},{"date":"2025-09-30","value":"3.07","vol":"4.84"},{"date":"2025-06-30","value":"2.87","vol":"5.30"},{"date":"2025-03-31","value":"3.06","vol":"6.35"},{"date":"2024-12-31","value":"2.68","vol":"5.40"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 速动比率 |
3.12 | 3.07 | 2.87 | 3.06 | 2.68 |
| 行业 | 3.38 | 4.84 | 5.30 | 6.35 | 5.40 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 6/71 ， 7/71。
[{"date":"2025-12-31","value":"32.42","vol":"28.78"},{"date":"2025-09-30","value":"32.50","vol":"28.18"},{"date":"2025-06-30","value":"33.79","vol":"26.73"},{"date":"2025-03-31","value":"33.71","vol":"26.03"},{"date":"2024-12-31","value":"33.73","vol":"25.81"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
32.42 | 32.50 | 33.79 | 33.71 | 33.73 |
| 行业(%) | 28.78 | 28.18 | 26.73 | 26.03 | 25.81 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"0.48","vol":"1.01"},{"date":"2025-09-30","value":"0.48","vol":"0.58"},{"date":"2025-06-30","value":"0.51","vol":"1.11"},{"date":"2025-03-31","value":"0.51","vol":"0.78"},{"date":"2024-12-31","value":"0.51","vol":"0.87"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.48 | 0.48 | 0.51 | 0.51 | 0.51 |
| 行业(%) | 1.01 | 0.58 | 1.11 | 0.78 | 0.87 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"1.09","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.20","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.86","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.54","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]